Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global NSAIDs Market Growth 2022-2028

  • LP 4901884
  • 105 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of NSAIDs will have significant change from previous year. According to our (LP Information) latest study, the global NSAIDs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global NSAIDs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States NSAIDs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global NSAIDs market, reaching US$ million by the year 2028. As for the Europe NSAIDs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main NSAIDs players cover Bayer, Novacap, Abbott, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of NSAIDs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Aspirin

Ibuprofen

Naproxen

Nabumetone

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Back Pain Treatment

Osteoarthritis Treatment

Other Disease Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer

Novacap

Abbott

Pfizer

Johnson & Johnson

Cigna

Geri-Care Pharmaceuticals

Perrigo Company

Kopran

Merck Sharp & Dohme

Sun Pharmaceutical Industries

GlaxoSmithKline

Reddy Pharmaceuticals

Verywell

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global NSAIDs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for NSAIDs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for NSAIDs by Country/Region, 2017, 2022 & 2028

2.2 NSAIDs Segment by Type

2.2.1 Aspirin

2.2.2 Ibuprofen

2.2.3 Naproxen

2.2.4 Nabumetone

2.2.5 Others

2.3 NSAIDs Sales by Type

2.3.1 Global NSAIDs Sales Market Share by Type (2017-2022)

2.3.2 Global NSAIDs Revenue and Market Share by Type (2017-2022)

2.3.3 Global NSAIDs Sale Price by Type (2017-2022)

2.4 NSAIDs Segment by Application

2.4.1 Back Pain Treatment

2.4.2 Osteoarthritis Treatment

2.4.3 Other Disease Treatment

2.5 NSAIDs Sales by Application

2.5.1 Global NSAIDs Sale Market Share by Application (2017-2022)

2.5.2 Global NSAIDs Revenue and Market Share by Application (2017-2022)

2.5.3 Global NSAIDs Sale Price by Application (2017-2022)

3 Global NSAIDs by Company

3.1 Global NSAIDs Breakdown Data by Company

3.1.1 Global NSAIDs Annual Sales by Company (2020-2022)

3.1.2 Global NSAIDs Sales Market Share by Company (2020-2022)

3.2 Global NSAIDs Annual Revenue by Company (2020-2022)

3.2.1 Global NSAIDs Revenue by Company (2020-2022)

3.2.2 Global NSAIDs Revenue Market Share by Company (2020-2022)

3.3 Global NSAIDs Sale Price by Company

3.4 Key Manufacturers NSAIDs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers NSAIDs Product Location Distribution

3.4.2 Players NSAIDs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for NSAIDs by Geographic Region

4.1 World Historic NSAIDs Market Size by Geographic Region (2017-2022)

4.1.1 Global NSAIDs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global NSAIDs Annual Revenue by Geographic Region

4.2 World Historic NSAIDs Market Size by Country/Region (2017-2022)

4.2.1 Global NSAIDs Annual Sales by Country/Region (2017-2022)

4.2.2 Global NSAIDs Annual Revenue by Country/Region

4.3 Americas NSAIDs Sales Growth

4.4 APAC NSAIDs Sales Growth

4.5 Europe NSAIDs Sales Growth

4.6 Middle East & Africa NSAIDs Sales Growth

5 Americas

5.1 Americas NSAIDs Sales by Country

5.1.1 Americas NSAIDs Sales by Country (2017-2022)

5.1.2 Americas NSAIDs Revenue by Country (2017-2022)

5.2 Americas NSAIDs Sales by Type

5.3 Americas NSAIDs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC NSAIDs Sales by Region

6.1.1 APAC NSAIDs Sales by Region (2017-2022)

6.1.2 APAC NSAIDs Revenue by Region (2017-2022)

6.2 APAC NSAIDs Sales by Type

6.3 APAC NSAIDs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe NSAIDs by Country

7.1.1 Europe NSAIDs Sales by Country (2017-2022)

7.1.2 Europe NSAIDs Revenue by Country (2017-2022)

7.2 Europe NSAIDs Sales by Type

7.3 Europe NSAIDs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa NSAIDs by Country

8.1.1 Middle East & Africa NSAIDs Sales by Country (2017-2022)

8.1.2 Middle East & Africa NSAIDs Revenue by Country (2017-2022)

8.2 Middle East & Africa NSAIDs Sales by Type

8.3 Middle East & Africa NSAIDs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of NSAIDs

10.3 Manufacturing Process Analysis of NSAIDs

10.4 Industry Chain Structure of NSAIDs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 NSAIDs Distributors

11.3 NSAIDs Customer

12 World Forecast Review for NSAIDs by Geographic Region

12.1 Global NSAIDs Market Size Forecast by Region

12.1.1 Global NSAIDs Forecast by Region (2023-2028)

12.1.2 Global NSAIDs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global NSAIDs Forecast by Type

12.7 Global NSAIDs Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer NSAIDs Product Offered

13.1.3 Bayer NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Novacap

13.2.1 Novacap Company Information

13.2.2 Novacap NSAIDs Product Offered

13.2.3 Novacap NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novacap Main Business Overview

13.2.5 Novacap Latest Developments

13.3 Abbott

13.3.1 Abbott Company Information

13.3.2 Abbott NSAIDs Product Offered

13.3.3 Abbott NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Abbott Main Business Overview

13.3.5 Abbott Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer NSAIDs Product Offered

13.4.3 Pfizer NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 Johnson & Johnson

13.5.1 Johnson & Johnson Company Information

13.5.2 Johnson & Johnson NSAIDs Product Offered

13.5.3 Johnson & Johnson NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Johnson & Johnson Main Business Overview

13.5.5 Johnson & Johnson Latest Developments

13.6 Cigna

13.6.1 Cigna Company Information

13.6.2 Cigna NSAIDs Product Offered

13.6.3 Cigna NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Cigna Main Business Overview

13.6.5 Cigna Latest Developments

13.7 Geri-Care Pharmaceuticals

13.7.1 Geri-Care Pharmaceuticals Company Information

13.7.2 Geri-Care Pharmaceuticals NSAIDs Product Offered

13.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Geri-Care Pharmaceuticals Main Business Overview

13.7.5 Geri-Care Pharmaceuticals Latest Developments

13.8 Perrigo Company

13.8.1 Perrigo Company Company Information

13.8.2 Perrigo Company NSAIDs Product Offered

13.8.3 Perrigo Company NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Perrigo Company Main Business Overview

13.8.5 Perrigo Company Latest Developments

13.9 Kopran

13.9.1 Kopran Company Information

13.9.2 Kopran NSAIDs Product Offered

13.9.3 Kopran NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Kopran Main Business Overview

13.9.5 Kopran Latest Developments

13.10 Merck Sharp & Dohme

13.10.1 Merck Sharp & Dohme Company Information

13.10.2 Merck Sharp & Dohme NSAIDs Product Offered

13.10.3 Merck Sharp & Dohme NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Merck Sharp & Dohme Main Business Overview

13.10.5 Merck Sharp & Dohme Latest Developments

13.11 Sun Pharmaceutical Industries

13.11.1 Sun Pharmaceutical Industries Company Information

13.11.2 Sun Pharmaceutical Industries NSAIDs Product Offered

13.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sun Pharmaceutical Industries Main Business Overview

13.11.5 Sun Pharmaceutical Industries Latest Developments

13.12 GlaxoSmithKline

13.12.1 GlaxoSmithKline Company Information

13.12.2 GlaxoSmithKline NSAIDs Product Offered

13.12.3 GlaxoSmithKline NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 GlaxoSmithKline Main Business Overview

13.12.5 GlaxoSmithKline Latest Developments

13.13 Reddy Pharmaceuticals

13.13.1 Reddy Pharmaceuticals Company Information

13.13.2 Reddy Pharmaceuticals NSAIDs Product Offered

13.13.3 Reddy Pharmaceuticals NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Reddy Pharmaceuticals Main Business Overview

13.13.5 Reddy Pharmaceuticals Latest Developments

13.14 Verywell

13.14.1 Verywell Company Information

13.14.2 Verywell NSAIDs Product Offered

13.14.3 Verywell NSAIDs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Verywell Main Business Overview

13.14.5 Verywell Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. NSAIDs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. NSAIDs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Aspirin

Table 4. Major Players of Ibuprofen

Table 5. Major Players of Naproxen

Table 6. Major Players of Nabumetone

Table 7. Major Players of Others

Table 8. Global NSAIDs Sales by Type (2017-2022) & (K Pcs)

Table 9. Global NSAIDs Sales Market Share by Type (2017-2022)

Table 10. Global NSAIDs Revenue by Type (2017-2022) & ($ million)

Table 11. Global NSAIDs Revenue Market Share by Type (2017-2022)

Table 12. Global NSAIDs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global NSAIDs Sales by Application (2017-2022) & (K Pcs)

Table 14. Global NSAIDs Sales Market Share by Application (2017-2022)

Table 15. Global NSAIDs Revenue by Application (2017-2022)

Table 16. Global NSAIDs Revenue Market Share by Application (2017-2022)

Table 17. Global NSAIDs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global NSAIDs Sales by Company (2020-2022) & (K Pcs)

Table 19. Global NSAIDs Sales Market Share by Company (2020-2022)

Table 20. Global NSAIDs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global NSAIDs Revenue Market Share by Company (2020-2022)

Table 22. Global NSAIDs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers NSAIDs Producing Area Distribution and Sales Area

Table 24. Players NSAIDs Products Offered

Table 25. NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global NSAIDs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global NSAIDs Sales Market Share Geographic Region (2017-2022)

Table 30. Global NSAIDs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global NSAIDs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global NSAIDs Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global NSAIDs Sales Market Share by Country/Region (2017-2022)

Table 34. Global NSAIDs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global NSAIDs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas NSAIDs Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas NSAIDs Sales Market Share by Country (2017-2022)

Table 38. Americas NSAIDs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas NSAIDs Revenue Market Share by Country (2017-2022)

Table 40. Americas NSAIDs Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas NSAIDs Sales Market Share by Type (2017-2022)

Table 42. Americas NSAIDs Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas NSAIDs Sales Market Share by Application (2017-2022)

Table 44. APAC NSAIDs Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC NSAIDs Sales Market Share by Region (2017-2022)

Table 46. APAC NSAIDs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC NSAIDs Revenue Market Share by Region (2017-2022)

Table 48. APAC NSAIDs Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC NSAIDs Sales Market Share by Type (2017-2022)

Table 50. APAC NSAIDs Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC NSAIDs Sales Market Share by Application (2017-2022)

Table 52. Europe NSAIDs Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe NSAIDs Sales Market Share by Country (2017-2022)

Table 54. Europe NSAIDs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe NSAIDs Revenue Market Share by Country (2017-2022)

Table 56. Europe NSAIDs Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe NSAIDs Sales Market Share by Type (2017-2022)

Table 58. Europe NSAIDs Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe NSAIDs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa NSAIDs Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa NSAIDs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa NSAIDs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa NSAIDs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa NSAIDs Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa NSAIDs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa NSAIDs Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa NSAIDs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of NSAIDs

Table 69. Key Market Challenges & Risks of NSAIDs

Table 70. Key Industry Trends of NSAIDs

Table 71. NSAIDs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. NSAIDs Distributors List

Table 74. NSAIDs Customer List

Table 75. Global NSAIDs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global NSAIDs Sales Market Forecast by Region

Table 77. Global NSAIDs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global NSAIDs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas NSAIDs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC NSAIDs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC NSAIDs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe NSAIDs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa NSAIDs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa NSAIDs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global NSAIDs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global NSAIDs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global NSAIDs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global NSAIDs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global NSAIDs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global NSAIDs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global NSAIDs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global NSAIDs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Bayer Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 96. Bayer NSAIDs Product Offered

Table 97. Bayer NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Bayer Main Business

Table 99. Bayer Latest Developments

Table 100. Novacap Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 101. Novacap NSAIDs Product Offered

Table 102. Novacap NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Novacap Main Business

Table 104. Novacap Latest Developments

Table 105. Abbott Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 106. Abbott NSAIDs Product Offered

Table 107. Abbott NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Abbott Main Business

Table 109. Abbott Latest Developments

Table 110. Pfizer Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 111. Pfizer NSAIDs Product Offered

Table 112. Pfizer NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Pfizer Main Business

Table 114. Pfizer Latest Developments

Table 115. Johnson & Johnson Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 116. Johnson & Johnson NSAIDs Product Offered

Table 117. Johnson & Johnson NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Johnson & Johnson Main Business

Table 119. Johnson & Johnson Latest Developments

Table 120. Cigna Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 121. Cigna NSAIDs Product Offered

Table 122. Cigna NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Cigna Main Business

Table 124. Cigna Latest Developments

Table 125. Geri-Care Pharmaceuticals Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 126. Geri-Care Pharmaceuticals NSAIDs Product Offered

Table 127. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Geri-Care Pharmaceuticals Main Business

Table 129. Geri-Care Pharmaceuticals Latest Developments

Table 130. Perrigo Company Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 131. Perrigo Company NSAIDs Product Offered

Table 132. Perrigo Company NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Perrigo Company Main Business

Table 134. Perrigo Company Latest Developments

Table 135. Kopran Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 136. Kopran NSAIDs Product Offered

Table 137. Kopran NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Kopran Main Business

Table 139. Kopran Latest Developments

Table 140. Merck Sharp & Dohme Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 141. Merck Sharp & Dohme NSAIDs Product Offered

Table 142. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Merck Sharp & Dohme Main Business

Table 144. Merck Sharp & Dohme Latest Developments

Table 145. Sun Pharmaceutical Industries Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 146. Sun Pharmaceutical Industries NSAIDs Product Offered

Table 147. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Sun Pharmaceutical Industries Main Business

Table 149. Sun Pharmaceutical Industries Latest Developments

Table 150. GlaxoSmithKline Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 151. GlaxoSmithKline NSAIDs Product Offered

Table 152. GlaxoSmithKline NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. GlaxoSmithKline Main Business

Table 154. GlaxoSmithKline Latest Developments

Table 155. Reddy Pharmaceuticals Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 156. Reddy Pharmaceuticals NSAIDs Product Offered

Table 157. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Reddy Pharmaceuticals Main Business

Table 159. Reddy Pharmaceuticals Latest Developments

Table 160. Verywell Basic Information, NSAIDs Manufacturing Base, Sales Area and Its Competitors

Table 161. Verywell NSAIDs Product Offered

Table 162. Verywell NSAIDs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Verywell Main Business

Table 164. Verywell Latest Developments

List of Figures

Figure 1. Picture of NSAIDs

Figure 2. NSAIDs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global NSAIDs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global NSAIDs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. NSAIDs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Aspirin

Figure 10. Product Picture of Ibuprofen

Figure 11. Product Picture of Naproxen

Figure 12. Product Picture of Nabumetone

Figure 13. Product Picture of Others

Figure 14. Global NSAIDs Sales Market Share by Type in 2021

Figure 15. Global NSAIDs Revenue Market Share by Type (2017-2022)

Figure 16. NSAIDs Consumed in Back Pain Treatment

Figure 17. Global NSAIDs Market: Back Pain Treatment (2017-2022) & (K Pcs)

Figure 18. NSAIDs Consumed in Osteoarthritis Treatment

Figure 19. Global NSAIDs Market: Osteoarthritis Treatment (2017-2022) & (K Pcs)

Figure 20. NSAIDs Consumed in Other Disease Treatment

Figure 21. Global NSAIDs Market: Other Disease Treatment (2017-2022) & (K Pcs)

Figure 22. Global NSAIDs Sales Market Share by Application (2017-2022)

Figure 23. Global NSAIDs Revenue Market Share by Application in 2021

Figure 24. NSAIDs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global NSAIDs Revenue Market Share by Company in 2021

Figure 26. Global NSAIDs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global NSAIDs Revenue Market Share by Geographic Region in 2021

Figure 28. Global NSAIDs Sales Market Share by Region (2017-2022)

Figure 29. Global NSAIDs Revenue Market Share by Country/Region in 2021

Figure 30. Americas NSAIDs Sales 2017-2022 (K Pcs)

Figure 31. Americas NSAIDs Revenue 2017-2022 ($ Millions)

Figure 32. APAC NSAIDs Sales 2017-2022 (K Pcs)

Figure 33. APAC NSAIDs Revenue 2017-2022 ($ Millions)

Figure 34. Europe NSAIDs Sales 2017-2022 (K Pcs)

Figure 35. Europe NSAIDs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa NSAIDs Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa NSAIDs Revenue 2017-2022 ($ Millions)

Figure 38. Americas NSAIDs Sales Market Share by Country in 2021

Figure 39. Americas NSAIDs Revenue Market Share by Country in 2021

Figure 40. United States NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC NSAIDs Sales Market Share by Region in 2021

Figure 45. APAC NSAIDs Revenue Market Share by Regions in 2021

Figure 46. China NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe NSAIDs Sales Market Share by Country in 2021

Figure 53. Europe NSAIDs Revenue Market Share by Country in 2021

Figure 54. Germany NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa NSAIDs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa NSAIDs Revenue Market Share by Country in 2021

Figure 61. Egypt NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country NSAIDs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of NSAIDs in 2021

Figure 67. Manufacturing Process Analysis of NSAIDs

Figure 68. Industry Chain Structure of NSAIDs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390